# Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway

> **NCT07237984** · — · NOT_YET_RECRUITING · sponsor: **Nordsjaellands Hospital** · enrollment: 2000 (estimated)

## Conditions studied

- Colorectal Cancer
- Colorectal Adenoma
- Inflammatory Bowel Disease (IBD)

## Interventions

- **DIAGNOSTIC_TEST:** Blood sampling
- **DIAGNOSTIC_TEST:** Stool samplong

## Key facts

- **NCT ID:** NCT07237984
- **Lead sponsor:** Nordsjaellands Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2028-11-30
- **Final completion:** 2031-12-31
- **Target enrollment:** 2000 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07237984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07237984, "Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07237984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*